TETRADECYL HYDROGEN SULFATE (ESTER)

TETRADECYL HYDROGEN SULFATE (ESTER) was reported 85 times

TETRADECYL HYDROGEN SULFATE (ESTER) is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NIH STROKE SCALE SCORE INCREASED 1 0.0120
1 PULMONARY ARTERY OCCLUSION 1 0.0104
2 VARICOSE ULCERATION 2 0.0072
3 AIR EMBOLISM 3 0.0064
4 ESCHAR 4 0.0055
5 RETINAL ARTERY EMBOLISM 1 0.0048
6 VISUAL BRIGHTNESS 1 0.0025
7 NEPHRITIS ALLERGIC 1 0.0025
8 NECROSIS ISCHAEMIC 1 0.0022
9 INJECTION SITE ULCER 2 0.0021
10 GLOMERULOSCLEROSIS 1 0.0016
11 GRANULOMA ANNULARE 1 0.0014
12 SERRATIA INFECTION 1 0.0013
13 PHYSICAL PRODUCT LABEL ISSUE 1 0.0008
14 CEREBRAL ARTERY EMBOLISM 1 0.0008
15 INJECTION SITE DISCOLOURATION 9 0.0007
16 INJECTION SITE HAEMATOMA 10 0.0007
17 EXPOSURE DURING BREAST FEEDING 2 0.0006
18 SKIN NECROSIS 3 0.0006
19 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 2 0.0005
20 ACCIDENTAL EXPOSURE 2 0.0005
21 ULCER 7 0.0004
22 PATELLA FRACTURE 1 0.0004
23 WEIGHT BEARING DIFFICULTY 1 0.0004
24 NECROSIS 2 0.0004
25 FAMILY STRESS 1 0.0003
26 HEPATIC CYST 1 0.0003
27 PROCEDURAL COMPLICATION 2 0.0003
28 ANAPHYLACTOID REACTION 1 0.0002
29 ABSCESS LIMB 1 0.0002
30 INJECTION SITE INFLAMMATION 1 0.0002
31 VEIN DISORDER 1 0.0002
32 INJECTION SITE INJURY 1 0.0002
33 INJECTION SITE VESICLES 1 0.0002
34 PRE-EXISTING CONDITION IMPROVED 1 0.0002
35 REFUSAL OF TREATMENT BY PATIENT 1 0.0002
36 FORMICATION 1 0.0001
37 ACIDOSIS 1 0.0001
38 MULTIPLE ALLERGIES 1 0.0001
39 SENSORY LOSS 1 0.0001
40 HEMIPARESIS 2 0.0001
41 SCAR 2 0.0001
42 UROSEPSIS 1 0.0001
43 POST PROCEDURAL COMPLICATION 2 0.0001
44 EAR DISCOMFORT 1 0.0001
45 TENDERNESS 1 0.0001
46 NEPHROPATHY TOXIC 1 0.0001
47 SCAB 1 0.0001
48 VASCULITIS 1 0.0001
49 WRIST FRACTURE 1 0.0001
50 INJECTION SITE EXTRAVASATION 1 0.0001
51 TOOTH EXTRACTION 1 0.0001
52 POISONING 1 0.0001
53 INJECTION SITE IRRITATION 1 0.0001
54 ANAPHYLACTIC SHOCK 2 0.0001
55 SKIN ULCER 2 0.0001
56 DRUG TOXICITY 1 0.0001
57 ORAL DISCOMFORT 1 0.0001
58 WOUND 2 0.0001
59 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
60 BONE LOSS 1 0.0001
61 APHASIA 2 0.0001
62 SENSORY DISTURBANCE 1 0.0001
63 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
64 BLOOD UREA INCREASED 1 0.0001
65 CELLULITIS 3 0.0001
66 WRONG TECHNIQUE IN DRUG USAGE PROCESS 2 0.0001
67 RESTLESS LEGS SYNDROME 1 0.0001
68 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
69 PROTEINURIA 1 0.0001
70 UPPER LIMB FRACTURE 1 0.0001
71 HYPERSENSITIVITY 9 0.0000
72 ROAD TRAFFIC ACCIDENT 2 0.0000
73 CHROMATURIA 1 0.0000
74 SKIN DISCOLOURATION 2 0.0000
75 SHOCK 1 0.0000
76 PRESYNCOPE 1 0.0000
77 NEURALGIA 1 0.0000
78 INFLAMMATION 2 0.0000
79 FEAR 1 0.0000
80 ANAPHYLACTIC REACTION 2 0.0000
81 ANGINA PECTORIS 1 0.0000
82 PRODUCT SUBSTITUTION ISSUE 2 0.0000
83 HEPATIC FAILURE 1 0.0000
84 LOSS OF CONSCIOUSNESS 4 0.0000
85 IMPAIRED HEALING 1 0.0000
86 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
87 EXPIRED PRODUCT ADMINISTERED 1 0.0000
88 ERYTHEMA 6 0.0000
89 EYE SWELLING 1 0.0000
90 INTESTINAL OBSTRUCTION 1 0.0000
91 BLINDNESS 1 0.0000
92 RENAL FAILURE ACUTE 1 0.0000
93 DEVICE DISLOCATION 1 0.0000
94 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
95 TINNITUS 1 0.0000
96 RENAL DISORDER 1 0.0000
97 NEUROPATHY PERIPHERAL 2 0.0000
98 DISEASE RECURRENCE 1 0.0000
99 HYPOAESTHESIA 3 0.0000
100 TREATMENT NONCOMPLIANCE 1 0.0000
101 OXYGEN SATURATION DECREASED 1 0.0000
102 LETHARGY 1 0.0000
103 EYE IRRITATION 1 0.0000
104 SURGERY 1 0.0000
105 WHEEZING 1 0.0000
106 INJECTION SITE PAIN 5 0.0000
107 INJECTION SITE ERYTHEMA 2 0.0000
108 SWELLING FACE 1 0.0000
109 BLOOD CREATININE INCREASED 1 0.0000
110 PRODUCT QUALITY ISSUE 2 0.0000
111 BURNING SENSATION 1 0.0000
112 DYSGEUSIA 1 0.0000
113 ACNE 1 0.0000
114 INJECTION SITE SWELLING 1 0.0000
115 CARDIAC FAILURE CONGESTIVE 1 0.0000
116 CARDIAC ARREST 1 0.0000
117 PRODUCT USE IN UNAPPROVED INDICATION 3 0.0000
118 SKIN EXFOLIATION 1 0.0000
119 CEREBROVASCULAR ACCIDENT 2 0.0000
120 GASTROINTESTINAL DISORDER 1 0.0000
121 MUSCLE SPASMS 2 0.0000
122 SWELLING 1 0.0000
123 PULMONARY EMBOLISM 1 0.0000
124 MIGRAINE 1 0.0000
125 PAIN IN EXTREMITY 3 0.0000
126 SYNCOPE 1 0.0000
127 FLUSHING 1 0.0000
128 CHEST DISCOMFORT 1 0.0000
129 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
130 HYPERTENSION 2 0.0000
131 INFLUENZA 1 0.0000
132 SEPSIS 1 0.0000
133 MUSCULAR WEAKNESS 1 0.0000
134 SEIZURE 1 0.0000
135 JOINT SWELLING 1 0.0000
136 OEDEMA PERIPHERAL 1 0.0000
137 VISUAL IMPAIRMENT 1 0.0000
138 HYPERHIDROSIS 1 0.0000
139 RENAL FAILURE 1 0.0000
140 DEHYDRATION 1 0.0000
141 VISION BLURRED 1 0.0000
142 INFECTION 1 0.0000
143 BLOOD PRESSURE INCREASED 1 0.0000
144 HOSPITALISATION 1 0.0000
145 PERIPHERAL SWELLING 1 0.0000
146 VOMITING 3 0.0000
147 PARAESTHESIA 1 0.0000
148 TREMOR 1 0.0000
149 URTICARIA 1 0.0000
150 MYALGIA 1 0.0000
151 NO ADVERSE EVENT 1 0.0000
152 NASOPHARYNGITIS 1 0.0000
153 CHEST PAIN 1 0.0000
154 ALOPECIA 1 0.0000
155 HYPOTENSION 1 0.0000
156 OVERDOSE 1 0.0000
157 FEELING ABNORMAL 1 0.0000
158 DIZZINESS 2 0.0000
159 NAUSEA 3 0.0000
160 COUGH 1 0.0000
161 HEADACHE 2 0.0000
162 DRUG INEFFECTIVE 4 0.0000
163 FALL 1 0.0000
164 ASTHENIA 1 0.0000
165 FATIGUE 2 0.0000
166 ARTHRALGIA 1 0.0000
167 RASH 1 0.0000
168 DYSPNOEA 1 0.0000
169 PAIN 1 0.0000
170 DIARRHOEA 1 0.0000